ROYAL BANK OF CANADA - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
247
-47.7%
0.00%
Q2 2023$1,000472
+673.8%
0.00%
Q1 2023$061
+1425.0%
0.00%
Q4 2022$04
-94.8%
0.00%
Q3 2022$0
-100.0%
77
-94.0%
0.00%
Q1 2022$3,000
-88.5%
1,284
-70.4%
0.00%
Q4 2021$26,000
+4.0%
4,343
+80.1%
0.00%
Q3 2021$25,000
+257.1%
2,411
+255.1%
0.00%
Q2 2021$7,000
-36.4%
679
-7.6%
0.00%
Q1 2021$11,0007350.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Alpha Wave Global, LP 213,658$3,104,0000.19%
Serengeti Asset Management LP 20,000$291,0000.13%
FORMULA GROWTH LTD 56,276$818,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 375,000$5,449,0000.12%
TUDOR INVESTMENT CORP ET AL 113,353$1,647,0000.03%
Duquesne Family Office 100,000$1,453,0000.03%
PURA VIDA INVESTMENTS, LLC 67,357$941,0000.03%
MOORE CAPITAL MANAGEMENT, LP 127,500$1,853,0000.02%
Zimmer Partners, LP 46,000$668,0000.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 26,000$376,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders